Standard Biotools (LAB) Other Working Capital Changes (2010 - 2026)
Standard Biotools' (LAB) quarterly Other Working Capital Changes came in at -$29.9 million in Q1 2026, down 1890.29% year-on-year from $1.7 million in Q1 2025, and down 474.0% on a QoQ basis from -$5.2 million in Q4 2025.
Standard Biotools (LAB) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 14 years of Other Working Capital Changes data on file, last reported at -$29.9 million in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 1890.29% year-over-year to -$29.9 million in Q1 2026; TTM through Mar 2026 was -$34.8 million, a 3673.85% decrease from a year earlier, with the FY2025 full-year figure at -$6.4 million, down 725.85% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$29.9 million, down from -$5.2 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for LAB reached as high as $1.9 million in Q2 2024 and fell as low as -$3.0 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged $87235.3 across 5 years, with a median of -$112000.0 in 2025.
- Across the five-year window, Other Working Capital Changes jumped 2226.61% in 2024 and tumbled 5963.95% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$3.3 million in 2022, then jumped by 120.32% to $666000.0 in 2023, then tumbled by 112.91% to -$86000.0 in 2024, then tumbled by 5963.95% to -$5.2 million in 2025, then tumbled by 474.0% to -$29.9 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$29.9 million in Q1 2026, -$5.2 million in Q4 2025, and -$1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn |
| 10 | Standard Biotools | 309.82 Mn | -145.35 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | 705,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | -112,000.00 |
| Mar 31, 2025 | -112,000.00 |
| Mar 31, 2025 | -112,000.00 |
| Dec 31, 2024 | -789,000.00 |
| Dec 31, 2024 | -789,000.00 |
| Dec 31, 2024 | -789,000.00 |
| Sep 30, 2024 | -573,000.00 |
| Sep 30, 2024 | -573,000.00 |